Clinical Trial Update: A Study to Evaluate Cutaneous Scar Quality Following Bilateral Breast Reduction With the PEAK PlasmaBlade 4.0 [NA]

View source ↗

Summary

The study evaluating scar quality after bilateral breast reduction using the PEAK PlasmaBlade 4.0 was terminated, but results were posted in January 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macromastia

Drugs mentioned

• PEAK PlasmaBlade 4.0

Snippet

Sponsor: Medtronic Surgical Technologies | Conditions: Macromastia | NA | Status: TERMINATED | Results posted: 2013-01-03